U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07154043) titled 'Comparison of IPC Therapy as an Alternative or an Adjunct to MLD Within CDT for BCRL' on Aug. 26.
Brief Summary: Breast cancer is the most common cancer among women worldwide and lymphedema is one of its most significant complications. Breast cancer-related lymphedema (BCRL) may develop shortly after treatment or even years later, causing physical and psychological burden, functional impairment, and reduced quality of life. Complete decongestive therapy (CDT), which includes manual lymph drainage (MLD), compression, skin care, and exercise, is the standard approach. Intermittent pneumatic compression (IPC) has been proposed as an ad...